Skip to main content
Top
Published in: Pituitary 2/2008

01-06-2008

Dynamic testing in Cushing’s syndrome

Authors: Blerina Kola, Ashley B. Grossman

Published in: Pituitary | Issue 2/2008

Login to get access

Abstract

Endogenous Cushing’s syndrome (CS) results from chronic exposure to excess glucocorticoids. CS can be ACTH-dependent, caused by ACTH-secreting pituitary or ectopic tumours, or ACTH-independent, caused by cortisol-secreting adrenal tumours. CS can be an extremely difficult diagnosis to make, and assessment will include clinical, biochemical and radiological evaluation. Several screening tests are used for the confirmation of hypercortisolaemia and its differentiation from other, more frequent, clinical abnormalities, such as simple obesity, hypertension, depression etc. Other dynamic tests are useful for establishing the aetiology. We have reviewed the current literature on the diagnosis of CS, and based on these data and our own experience, suggest the most useful tests and diagnostic criteria to be used. We conclude that even though laboratory testing is a fundamental part of the investigation of patients with CS, the interpretation of the tests should always be performed with extreme care, as none of the tests has proven fully capable of distinguishing all cases of CS. The biochemical results should be interpreted jointly with the clinical aspects and the radiology findings in a probabilistic matrix, and not as part of a uniform algorithm.
Literature
1.
go back to reference Ross NS (1994) Epidemiology of Cushing’s syndrome and subclinical disease. Endocrinol Metab Clin North Am 23:539–546PubMed Ross NS (1994) Epidemiology of Cushing’s syndrome and subclinical disease. Endocrinol Metab Clin North Am 23:539–546PubMed
2.
go back to reference Plotz CM, Knowlton AI, Ragan C (1952) The natural history of Cushing’s syndrome. Am J Med 13:597–614PubMedCrossRef Plotz CM, Knowlton AI, Ragan C (1952) The natural history of Cushing’s syndrome. Am J Med 13:597–614PubMedCrossRef
3.
go back to reference Lacroix A, Bourdeau I (2005) Bilateral adrenal Cushing’s syndrome: macronodular adrenal hyperplasia and primary pigmented nodular adrenocortical disease. Endocrinol Metab Clin North Am 34:441–458PubMedCrossRef Lacroix A, Bourdeau I (2005) Bilateral adrenal Cushing’s syndrome: macronodular adrenal hyperplasia and primary pigmented nodular adrenocortical disease. Endocrinol Metab Clin North Am 34:441–458PubMedCrossRef
4.
go back to reference Lacroix A, Baldacchino V, Bourdeau I, Hamet P, Tremblay J (2004) Cushing’s syndrome variants secondary to aberrant hormone receptors. Trends Endocrinol Metab 15:375–382PubMed Lacroix A, Baldacchino V, Bourdeau I, Hamet P, Tremblay J (2004) Cushing’s syndrome variants secondary to aberrant hormone receptors. Trends Endocrinol Metab 15:375–382PubMed
5.
go back to reference Young WF Jr., Carney JA, Musa BU, Wulffraat NM, Lens JW, Drexhage HA (1989) Familial Cushing’s syndrome due to primary pigmented nodular adrenocortical disease. Reinvestigation 50 years later. N Engl J Med 321:1659–1664PubMedCrossRef Young WF Jr., Carney JA, Musa BU, Wulffraat NM, Lens JW, Drexhage HA (1989) Familial Cushing’s syndrome due to primary pigmented nodular adrenocortical disease. Reinvestigation 50 years later. N Engl J Med 321:1659–1664PubMedCrossRef
6.
go back to reference Newell-Price J, Bertagna X, Grossman AB, Nieman LK (2006) Cushing’s syndrome. Lancet 367:1605–1617PubMedCrossRef Newell-Price J, Bertagna X, Grossman AB, Nieman LK (2006) Cushing’s syndrome. Lancet 367:1605–1617PubMedCrossRef
7.
go back to reference Arnaldi G, Angeli A, Atkinson AB et al (2003) Diagnosis and complications of Cushing’s syndrome: a consensus statement. J Clin Endocrinol Metab 88:5593–5602PubMedCrossRef Arnaldi G, Angeli A, Atkinson AB et al (2003) Diagnosis and complications of Cushing’s syndrome: a consensus statement. J Clin Endocrinol Metab 88:5593–5602PubMedCrossRef
8.
go back to reference Newell-Price J, Grossman A (1999) Diagnosis and management of Cushing’s syndrome. Lancet 353:2087–2088PubMedCrossRef Newell-Price J, Grossman A (1999) Diagnosis and management of Cushing’s syndrome. Lancet 353:2087–2088PubMedCrossRef
9.
go back to reference Nieman LK, Ilias I (2005) Evaluation and treatment of Cushing’s syndrome. Am J Med 118:1340–1346PubMedCrossRef Nieman LK, Ilias I (2005) Evaluation and treatment of Cushing’s syndrome. Am J Med 118:1340–1346PubMedCrossRef
10.
go back to reference Newell-Price J, Trainer P, Besser M, Grossman A (1998) The diagnosis and differential diagnosis of Cushing’s syndrome and pseudo-Cushing’s states. Endocrine Rev 19:647–672CrossRef Newell-Price J, Trainer P, Besser M, Grossman A (1998) The diagnosis and differential diagnosis of Cushing’s syndrome and pseudo-Cushing’s states. Endocrine Rev 19:647–672CrossRef
11.
go back to reference Cizza G, Nieman LK, Doppman JL et al (1996) Factitious Cushing syndrome. J Clin Endocrinol Metab 81:3573–3577PubMedCrossRef Cizza G, Nieman LK, Doppman JL et al (1996) Factitious Cushing syndrome. J Clin Endocrinol Metab 81:3573–3577PubMedCrossRef
12.
go back to reference Yanovski JA, Cutler GB Jr., Chrousos GP, Nieman LK (1993) Corticotropin-releasing hormone stimulation following low-dose dexamethasone administration. A new test to distinguish Cushing’s syndrome from pseudo-Cushing’s states. JAMA 269:2232–2238PubMedCrossRef Yanovski JA, Cutler GB Jr., Chrousos GP, Nieman LK (1993) Corticotropin-releasing hormone stimulation following low-dose dexamethasone administration. A new test to distinguish Cushing’s syndrome from pseudo-Cushing’s states. JAMA 269:2232–2238PubMedCrossRef
13.
go back to reference Makras P, Toloumis G, Papadogias D, Kaltsas GA, Besser M (2006) The diagnosis and differential diagnosis of endogenous Cushing’s syndrome. Hormones (Athens) 5:231–250 Makras P, Toloumis G, Papadogias D, Kaltsas GA, Besser M (2006) The diagnosis and differential diagnosis of endogenous Cushing’s syndrome. Hormones (Athens) 5:231–250
14.
go back to reference Wood PJ, Barth JH, Freedman DB, Perry L, Sheridan B (1997) Evidence for the low dose dexamethasone suppression test to screen for Cushing’s syndrome–recommendations for a protocol for biochemistry laboratories. Ann Clin Biochem 34(Pt 3):222–229PubMed Wood PJ, Barth JH, Freedman DB, Perry L, Sheridan B (1997) Evidence for the low dose dexamethasone suppression test to screen for Cushing’s syndrome–recommendations for a protocol for biochemistry laboratories. Ann Clin Biochem 34(Pt 3):222–229PubMed
15.
go back to reference Kennedy L, Atkinson AB, Johnston H, Sheridan B, Hadden DR (1984) Serum cortisol concentrations during low dose dexamethasone suppression test to screen for Cushing’s syndrome. Br Med J (Clin Res Ed) 289:1188–1191CrossRef Kennedy L, Atkinson AB, Johnston H, Sheridan B, Hadden DR (1984) Serum cortisol concentrations during low dose dexamethasone suppression test to screen for Cushing’s syndrome. Br Med J (Clin Res Ed) 289:1188–1191CrossRef
16.
go back to reference Newell-Price J, Trainer P, Perry L, Wass J, Grossman A, Besser M (1995) A single sleeping midnight cortisol has 100% sensitivity for the diagnosis of Cushing’s syndrome. Clin Endocrinol (Oxf) 43:545–550CrossRef Newell-Price J, Trainer P, Perry L, Wass J, Grossman A, Besser M (1995) A single sleeping midnight cortisol has 100% sensitivity for the diagnosis of Cushing’s syndrome. Clin Endocrinol (Oxf) 43:545–550CrossRef
17.
go back to reference Putignano P, Kaltsas GA, Satta MA, Grossman AB (1998) The effects of anti-convulsant drugs on adrenal function. Horm Metab Res 30:389–397PubMed Putignano P, Kaltsas GA, Satta MA, Grossman AB (1998) The effects of anti-convulsant drugs on adrenal function. Horm Metab Res 30:389–397PubMed
18.
go back to reference Papanicolaou DA, Mullen N, Kyrou I, Nieman LK (2002) Nighttime salivary cortisol: a useful test for the diagnosis of Cushing’s syndrome. J Clin Endocrinol Metab 87:4515–4521PubMedCrossRef Papanicolaou DA, Mullen N, Kyrou I, Nieman LK (2002) Nighttime salivary cortisol: a useful test for the diagnosis of Cushing’s syndrome. J Clin Endocrinol Metab 87:4515–4521PubMedCrossRef
19.
go back to reference Raff H, Raff JL, Findling JW (1998) Late-night salivary cortisol as a screening test for Cushing’s syndrome. J Clin Endocrinol Metab 83:2681–2686PubMedCrossRef Raff H, Raff JL, Findling JW (1998) Late-night salivary cortisol as a screening test for Cushing’s syndrome. J Clin Endocrinol Metab 83:2681–2686PubMedCrossRef
20.
go back to reference Findling JW, Raff H (2006) Cushing’s Syndrome: important issues in diagnosis and management. J Clin Endocrinol Metab 91:3746–3753PubMedCrossRef Findling JW, Raff H (2006) Cushing’s Syndrome: important issues in diagnosis and management. J Clin Endocrinol Metab 91:3746–3753PubMedCrossRef
21.
go back to reference Papanicolaou DA, Yanovski JA, Cutler GB Jr., Chrousos GP, Nieman LK (1998) A single midnight serum cortisol measurement distinguishes Cushing’s syndrome from pseudo-Cushing states. J Clin Endocrinol Metab 83:1163–1167PubMedCrossRef Papanicolaou DA, Yanovski JA, Cutler GB Jr., Chrousos GP, Nieman LK (1998) A single midnight serum cortisol measurement distinguishes Cushing’s syndrome from pseudo-Cushing states. J Clin Endocrinol Metab 83:1163–1167PubMedCrossRef
22.
go back to reference Putignano P, Toja P, Dubini A, Pecori GF, Corsello SM, Cavagnini F (2003) Midnight salivary cortisol versus urinary free and midnight serum cortisol as screening tests for Cushing’s syndrome. J Clin Endocrinol Metab 88:4153–4157PubMedCrossRef Putignano P, Toja P, Dubini A, Pecori GF, Corsello SM, Cavagnini F (2003) Midnight salivary cortisol versus urinary free and midnight serum cortisol as screening tests for Cushing’s syndrome. J Clin Endocrinol Metab 88:4153–4157PubMedCrossRef
23.
go back to reference Baid SK, Sinaii N, Wade M, Rubino D, Nieman LK (2007) Radioimmunoassay and tandem mass spectrometry measurement of bedtime salivary cortisol levels: a comparison of assays to establish hypercortisolism. J Clin Endocrinol Metab 92:3102–3107PubMedCrossRef Baid SK, Sinaii N, Wade M, Rubino D, Nieman LK (2007) Radioimmunoassay and tandem mass spectrometry measurement of bedtime salivary cortisol levels: a comparison of assays to establish hypercortisolism. J Clin Endocrinol Metab 92:3102–3107PubMedCrossRef
24.
go back to reference Castro M, Elias PC, Quidute AR, Halah FP, Moreira AC (1999) Out-patient screening for Cushing’s syndrome: the sensitivity of the combination of circadian rhythm and overnight dexamethasone suppression salivary cortisol tests. J Clin Endocrinol Metab 84:878–882PubMedCrossRef Castro M, Elias PC, Quidute AR, Halah FP, Moreira AC (1999) Out-patient screening for Cushing’s syndrome: the sensitivity of the combination of circadian rhythm and overnight dexamethasone suppression salivary cortisol tests. J Clin Endocrinol Metab 84:878–882PubMedCrossRef
25.
go back to reference Hellman L, Weitzman ED, Roffwarg H, Fukushima DK, Yoshida K (1970) Cortisol is secreted episodically in Cushing’s syndrome. J Clin Endocrinol Metab 30:686–689PubMedCrossRef Hellman L, Weitzman ED, Roffwarg H, Fukushima DK, Yoshida K (1970) Cortisol is secreted episodically in Cushing’s syndrome. J Clin Endocrinol Metab 30:686–689PubMedCrossRef
26.
go back to reference Krieger DT, Allen W, Rizzo F, Krieger HP (1971) Characterization of the normal temporal pattern of plasma corticosteroid levels. J Clin Endocrinol Metab 32:266–284PubMed Krieger DT, Allen W, Rizzo F, Krieger HP (1971) Characterization of the normal temporal pattern of plasma corticosteroid levels. J Clin Endocrinol Metab 32:266–284PubMed
27.
28.
go back to reference Butler PW, Besser GM (1968) Pituitary-adrenal function in severe depressive illness. Lancet 1:1234–1236PubMedCrossRef Butler PW, Besser GM (1968) Pituitary-adrenal function in severe depressive illness. Lancet 1:1234–1236PubMedCrossRef
29.
go back to reference Ross RJ, Miell JP, Holly JM et al (1991) Levels of GH binding activity, IGFBP-1, insulin, blood glucose and cortisol in intensive care patients. Clin Endocrinol (Oxf) 35:361–367CrossRef Ross RJ, Miell JP, Holly JM et al (1991) Levels of GH binding activity, IGFBP-1, insulin, blood glucose and cortisol in intensive care patients. Clin Endocrinol (Oxf) 35:361–367CrossRef
30.
go back to reference Reimondo G, Allasino B, Bovio S, Paccotti P, Angeli A, Terzolo M (2005) Evaluation of the effectiveness of midnight serum cortisol in the diagnostic procedures for Cushing’s syndrome. Eur J Endocrinol 153:803–809PubMedCrossRef Reimondo G, Allasino B, Bovio S, Paccotti P, Angeli A, Terzolo M (2005) Evaluation of the effectiveness of midnight serum cortisol in the diagnostic procedures for Cushing’s syndrome. Eur J Endocrinol 153:803–809PubMedCrossRef
31.
go back to reference Martin NM, Dhillo WS, Banerjee A et al (2006) Comparison of the dexamethasone-suppressed corticotropin-releasing hormone test and low-dose dexamethasone suppression test in the diagnosis of Cushing’s syndrome. J Clin Endocrinol Metab 91:2582–2586PubMedCrossRef Martin NM, Dhillo WS, Banerjee A et al (2006) Comparison of the dexamethasone-suppressed corticotropin-releasing hormone test and low-dose dexamethasone suppression test in the diagnosis of Cushing’s syndrome. J Clin Endocrinol Metab 91:2582–2586PubMedCrossRef
32.
go back to reference Gatta B, Chabre O, Cortet C et al (2007) Reevaluation of the combined dexamethasone suppression-corticotropin-releasing hormone test for differentiation of mild Cushing’s disease from pseudo-Cushing’s Syndrome. J Clin Endocrinol Metab 92:4290–4293PubMedCrossRef Gatta B, Chabre O, Cortet C et al (2007) Reevaluation of the combined dexamethasone suppression-corticotropin-releasing hormone test for differentiation of mild Cushing’s disease from pseudo-Cushing’s Syndrome. J Clin Endocrinol Metab 92:4290–4293PubMedCrossRef
33.
go back to reference Pecori GF, Pivonello R, Ambrogio AG et al (2007) The dexamethasone-suppressed corticotropin-releasing hormone stimulation test and the desmopressin test to distinguish Cushing’s syndrome from pseudo-Cushing’s states. Clin Endocrinol (Oxf) 66:251–257CrossRef Pecori GF, Pivonello R, Ambrogio AG et al (2007) The dexamethasone-suppressed corticotropin-releasing hormone stimulation test and the desmopressin test to distinguish Cushing’s syndrome from pseudo-Cushing’s states. Clin Endocrinol (Oxf) 66:251–257CrossRef
34.
go back to reference Erickson D, Natt N, Nippoldt T et al (2007) Dexamethasone-suppressed corticotropin-releasing hormone stimulation test for diagnosis of mild hypercortisolism. J Clin Endocrinol Metab 92:2972–2976PubMedCrossRef Erickson D, Natt N, Nippoldt T et al (2007) Dexamethasone-suppressed corticotropin-releasing hormone stimulation test for diagnosis of mild hypercortisolism. J Clin Endocrinol Metab 92:2972–2976PubMedCrossRef
35.
go back to reference Nieman L (2007) Editorial: The dexamethasone-suppressed corticotropin-releasing hormone test for the diagnosis of Cushing’s syndrome: what have we learned in 14 years? J Clin Endocrinol Metab 92:2876–2878PubMedCrossRef Nieman L (2007) Editorial: The dexamethasone-suppressed corticotropin-releasing hormone test for the diagnosis of Cushing’s syndrome: what have we learned in 14 years? J Clin Endocrinol Metab 92:2876–2878PubMedCrossRef
36.
go back to reference Lindsay JR, Nieman LK (2005) Differential diagnosis and imaging in Cushing’s syndrome. Endocrinol Metab Clin North Am 34:403–21PubMedCrossRef Lindsay JR, Nieman LK (2005) Differential diagnosis and imaging in Cushing’s syndrome. Endocrinol Metab Clin North Am 34:403–21PubMedCrossRef
37.
38.
go back to reference Howlett TA, Drury PL, Perry L, Doniach I, Rees LH, Besser GM (1986) Diagnosis and management of ACTH-dependent Cushing’s syndrome: comparison of the features in ectopic and pituitary ACTH production. Clin Endocrinol (Oxf) 24:699–713CrossRef Howlett TA, Drury PL, Perry L, Doniach I, Rees LH, Besser GM (1986) Diagnosis and management of ACTH-dependent Cushing’s syndrome: comparison of the features in ectopic and pituitary ACTH production. Clin Endocrinol (Oxf) 24:699–713CrossRef
39.
go back to reference Putignano P, Kaltsas GA, Korbonits M et al (2000) Alterations in serum protein levels in patients with Cushing’s syndrome before and after successful treatment. J Clin Endocrinol Metab 85:3309–3312PubMedCrossRef Putignano P, Kaltsas GA, Korbonits M et al (2000) Alterations in serum protein levels in patients with Cushing’s syndrome before and after successful treatment. J Clin Endocrinol Metab 85:3309–3312PubMedCrossRef
40.
go back to reference Aron DC, Raff H, Findling JW (1997) Effectiveness versus efficacy: the limited value in clinical practice of high dose dexamethasone suppression testing in the differential diagnosis of adrenocorticotropin-dependent Cushing’s syndrome. J Clin Endocrinol Metab 82:1780–1785PubMedCrossRef Aron DC, Raff H, Findling JW (1997) Effectiveness versus efficacy: the limited value in clinical practice of high dose dexamethasone suppression testing in the differential diagnosis of adrenocorticotropin-dependent Cushing’s syndrome. J Clin Endocrinol Metab 82:1780–1785PubMedCrossRef
41.
go back to reference Dichek HL, Nieman LK, Oldfield EH, Pass HI, Malley JD, Cutler GB Jr. (1994) A comparison of the standard high dose dexamethasone suppression test and the overnight 8-mg dexamethasone suppression test for the differential diagnosis of adrenocorticotropin-dependent Cushing’s syndrome. J Clin Endocrinol Metab 78:418–422PubMedCrossRef Dichek HL, Nieman LK, Oldfield EH, Pass HI, Malley JD, Cutler GB Jr. (1994) A comparison of the standard high dose dexamethasone suppression test and the overnight 8-mg dexamethasone suppression test for the differential diagnosis of adrenocorticotropin-dependent Cushing’s syndrome. J Clin Endocrinol Metab 78:418–422PubMedCrossRef
42.
go back to reference Tyrrell JB, Findling JW, Aron DC, Fitzgerald PA, Forsham PH (1986) An overnight high-dose dexamethasone suppression test for rapid differential diagnosis of Cushing’s syndrome. Ann Intern Med 104:180–186PubMed Tyrrell JB, Findling JW, Aron DC, Fitzgerald PA, Forsham PH (1986) An overnight high-dose dexamethasone suppression test for rapid differential diagnosis of Cushing’s syndrome. Ann Intern Med 104:180–186PubMed
43.
go back to reference Bruno OD, Rossi MA, Contreras LN et al (1985) Nocturnal high-dose dexamethasone suppression test in the aetiological diagnosis of Cushing’s syndrome. Acta Endocrinol (Copenh) 109:158–162 Bruno OD, Rossi MA, Contreras LN et al (1985) Nocturnal high-dose dexamethasone suppression test in the aetiological diagnosis of Cushing’s syndrome. Acta Endocrinol (Copenh) 109:158–162
44.
go back to reference Findling JW, Raff H, Aron DC (2004) The low-dose dexamethasone suppression test: a reevaluation in patients with Cushing’s syndrome. J Clin Endocrinol Metab 89:1222–1226PubMedCrossRef Findling JW, Raff H, Aron DC (2004) The low-dose dexamethasone suppression test: a reevaluation in patients with Cushing’s syndrome. J Clin Endocrinol Metab 89:1222–1226PubMedCrossRef
45.
go back to reference Isidori AM, Kaltsas GA, Mohammed S et al (2003) Discriminatory value of the low-dose dexamethasone suppression test in establishing the diagnosis and differential diagnosis of Cushing’s syndrome. J Clin Endocrinol Metab 88:5299–5306PubMedCrossRef Isidori AM, Kaltsas GA, Mohammed S et al (2003) Discriminatory value of the low-dose dexamethasone suppression test in establishing the diagnosis and differential diagnosis of Cushing’s syndrome. J Clin Endocrinol Metab 88:5299–5306PubMedCrossRef
46.
go back to reference Dias R, Storr HL, Perry LA, Isidori AM, Grossman AB, Savage MO (2006) The discriminatory value of the low-dose dexamethasone suppression test in the investigation of paediatric Cushing’s syndrome. Horm Res 65:159–162PubMedCrossRef Dias R, Storr HL, Perry LA, Isidori AM, Grossman AB, Savage MO (2006) The discriminatory value of the low-dose dexamethasone suppression test in the investigation of paediatric Cushing’s syndrome. Horm Res 65:159–162PubMedCrossRef
47.
go back to reference Trainer PJ, Faria M, Newell-Price J et al (1995) A comparison of the effects of human and ovine corticotropin-releasing hormone on the pituitary-adrenal axis. J Clin Endocrinol Metab 80:412–417PubMedCrossRef Trainer PJ, Faria M, Newell-Price J et al (1995) A comparison of the effects of human and ovine corticotropin-releasing hormone on the pituitary-adrenal axis. J Clin Endocrinol Metab 80:412–417PubMedCrossRef
48.
go back to reference Newell-Price J, Morris DG, Drake WM et al (2002) Optimal response criteria for the human CRH test in the differential diagnosis of ACTH-dependent Cushing’s syndrome. J Clin Endocrinol Metab 87:1640–1645PubMedCrossRef Newell-Price J, Morris DG, Drake WM et al (2002) Optimal response criteria for the human CRH test in the differential diagnosis of ACTH-dependent Cushing’s syndrome. J Clin Endocrinol Metab 87:1640–1645PubMedCrossRef
49.
go back to reference Invitti C, Pecori GF, de Martin M, Cavagnini F (1999) Diagnosis and management of Cushing’s syndrome: results of an Italian multicentre study. Study Group of the Italian Society of Endocrinology on the Pathophysiology of the Hypothalamic-Pituitary-Adrenal Axis. J Clin Endocrinol Metab 84:440–448PubMedCrossRef Invitti C, Pecori GF, de Martin M, Cavagnini F (1999) Diagnosis and management of Cushing’s syndrome: results of an Italian multicentre study. Study Group of the Italian Society of Endocrinology on the Pathophysiology of the Hypothalamic-Pituitary-Adrenal Axis. J Clin Endocrinol Metab 84:440–448PubMedCrossRef
50.
go back to reference Nieman LK, Oldfield EH, Wesley R, Chrousos GP, Loriaux DL, Cutler GB Jr. (1993) A simplified morning ovine corticotropin-releasing hormone stimulation test for the differential diagnosis of adrenocorticotropin-dependent Cushing’s syndrome. J Clin Endocrinol Metab 77:1308–1312PubMedCrossRef Nieman LK, Oldfield EH, Wesley R, Chrousos GP, Loriaux DL, Cutler GB Jr. (1993) A simplified morning ovine corticotropin-releasing hormone stimulation test for the differential diagnosis of adrenocorticotropin-dependent Cushing’s syndrome. J Clin Endocrinol Metab 77:1308–1312PubMedCrossRef
51.
go back to reference Tabarin A, San Galli F, Dezou S et al (1990) The corticotropin-releasing factor test in the differential diagnosis of Cushing’s syndrome: a comparison with the lysine-vasopressin test. Acta Endocrinol (Copenh) 123:331–338 Tabarin A, San Galli F, Dezou S et al (1990) The corticotropin-releasing factor test in the differential diagnosis of Cushing’s syndrome: a comparison with the lysine-vasopressin test. Acta Endocrinol (Copenh) 123:331–338
52.
go back to reference Malerbi DA, Mendonca BB, Liberman B et al (1993) The desmopressin stimulation test in the differential diagnosis of Cushing’s syndrome. Clin Endocrinol (Oxf) 38:463–472CrossRef Malerbi DA, Mendonca BB, Liberman B et al (1993) The desmopressin stimulation test in the differential diagnosis of Cushing’s syndrome. Clin Endocrinol (Oxf) 38:463–472CrossRef
53.
go back to reference Newell-Price J, Perry L, Medbak S et al (1997) A combined test using desmopressin and corticotropin-releasing hormone in the differential diagnosis of Cushing’s syndrome. J Clin Endocrinol Metab 82:176–181PubMedCrossRef Newell-Price J, Perry L, Medbak S et al (1997) A combined test using desmopressin and corticotropin-releasing hormone in the differential diagnosis of Cushing’s syndrome. J Clin Endocrinol Metab 82:176–181PubMedCrossRef
54.
go back to reference Tsagarakis S, Tsigos C, Vasiliou V et al (2002) The desmopressin and combined CRH-desmopressin tests in the differential diagnosis of ACTH-dependent Cushing’s syndrome: constraints imposed by the expression of V2 vasopressin receptors in tumors with ectopic ACTH secretion. J Clin Endocrinol Metab 87:1646–1653PubMedCrossRef Tsagarakis S, Tsigos C, Vasiliou V et al (2002) The desmopressin and combined CRH-desmopressin tests in the differential diagnosis of ACTH-dependent Cushing’s syndrome: constraints imposed by the expression of V2 vasopressin receptors in tumors with ectopic ACTH secretion. J Clin Endocrinol Metab 87:1646–1653PubMedCrossRef
55.
go back to reference Malerbi DA, Fragoso MC, Vieira Filho AH, Brenlha EM, Mendonca BB (1996) Cortisol and adrenocorticotropin response to desmopressin in women with Cushing’s disease compared with depressive illness. J Clin Endocrinol Metab 81:2233–2237PubMedCrossRef Malerbi DA, Fragoso MC, Vieira Filho AH, Brenlha EM, Mendonca BB (1996) Cortisol and adrenocorticotropin response to desmopressin in women with Cushing’s disease compared with depressive illness. J Clin Endocrinol Metab 81:2233–2237PubMedCrossRef
56.
go back to reference Korbonits M, Kaltsas G, Perry LA et al (1999) The growth hormone secretagogue hexarelin stimulates the hypothalamo-pituitary-adrenal axis via arginine vasopressin. J Clin Endocrinol Metab 84:2489–2495PubMedCrossRef Korbonits M, Kaltsas G, Perry LA et al (1999) The growth hormone secretagogue hexarelin stimulates the hypothalamo-pituitary-adrenal axis via arginine vasopressin. J Clin Endocrinol Metab 84:2489–2495PubMedCrossRef
57.
go back to reference Ghigo E, Arvat E, Ramunni J et al (1997) Adrenocorticotropin- and cortisol-releasing effect of hexarelin, a synthetic growth hormone-releasing peptide, in normal subjects and patients with Cushing’s syndrome. J Clin Endocrinol Metab 82:2439–2444PubMedCrossRef Ghigo E, Arvat E, Ramunni J et al (1997) Adrenocorticotropin- and cortisol-releasing effect of hexarelin, a synthetic growth hormone-releasing peptide, in normal subjects and patients with Cushing’s syndrome. J Clin Endocrinol Metab 82:2439–2444PubMedCrossRef
58.
go back to reference Arvat E, Giordano R, Ramunni J et al (1998) Adrenocorticotropin and cortisol hyperresponsiveness to hexarelin in patients with Cushing’s disease bearing a pituitary microadenoma, but not in those with macroadenoma. J Clin Endocrinol Metab 83:4207–4211PubMedCrossRef Arvat E, Giordano R, Ramunni J et al (1998) Adrenocorticotropin and cortisol hyperresponsiveness to hexarelin in patients with Cushing’s disease bearing a pituitary microadenoma, but not in those with macroadenoma. J Clin Endocrinol Metab 83:4207–4211PubMedCrossRef
59.
go back to reference Korbonits M, Jacobs RA, Aylwin SJ et al (1998) Expression of the growth hormone secretagogue receptor in pituitary adenomas and other neuroendocrine tumors. J Clin Endocrinol Metab 83:3624–3630PubMedCrossRef Korbonits M, Jacobs RA, Aylwin SJ et al (1998) Expression of the growth hormone secretagogue receptor in pituitary adenomas and other neuroendocrine tumors. J Clin Endocrinol Metab 83:3624–3630PubMedCrossRef
60.
go back to reference Arnaldi G, Mancini T, Kola B et al (2003) Cyclical Cushing’s syndrome in a patient with a bronchial neuroendocrine tumor (typical carcinoid) expressing ghrelin and growth hormone secretagogue receptors. J Clin Endocrinol Metab 88:5834–5840PubMedCrossRef Arnaldi G, Mancini T, Kola B et al (2003) Cyclical Cushing’s syndrome in a patient with a bronchial neuroendocrine tumor (typical carcinoid) expressing ghrelin and growth hormone secretagogue receptors. J Clin Endocrinol Metab 88:5834–5840PubMedCrossRef
61.
go back to reference Machado MC, Sa SV, Goldbaum TS et al (2007) In vivo response to growth hormone-releasing peptide-6 in adrenocorticotropin-dependent Cushing’s syndrome by lung carcinoid tumor is associated with growth hormone secretagogue receptor type 1a mRNA expression. J Endocrinol Invest 30:334–340PubMed Machado MC, Sa SV, Goldbaum TS et al (2007) In vivo response to growth hormone-releasing peptide-6 in adrenocorticotropin-dependent Cushing’s syndrome by lung carcinoid tumor is associated with growth hormone secretagogue receptor type 1a mRNA expression. J Endocrinol Invest 30:334–340PubMed
62.
go back to reference Kaltsas GA, Giannulis MG, Newell-Price JD et al (1999) A critical analysis of the value of simultaneous inferior petrosal sinus sampling in Cushing’s disease and the occult ectopic adrenocorticotropin syndrome. J Clin Endocrinol Metab 84:487–492PubMedCrossRef Kaltsas GA, Giannulis MG, Newell-Price JD et al (1999) A critical analysis of the value of simultaneous inferior petrosal sinus sampling in Cushing’s disease and the occult ectopic adrenocorticotropin syndrome. J Clin Endocrinol Metab 84:487–492PubMedCrossRef
63.
go back to reference Kaskarelis IS, Tsatalou EG, Benakis SV et al (2006) Bilateral inferior petrosal sinuses sampling in the routine investigation of Cushing’s syndrome: a comparison with MRI. AJR Am J Roentgenol 187:562–570PubMedCrossRef Kaskarelis IS, Tsatalou EG, Benakis SV et al (2006) Bilateral inferior petrosal sinuses sampling in the routine investigation of Cushing’s syndrome: a comparison with MRI. AJR Am J Roentgenol 187:562–570PubMedCrossRef
64.
go back to reference Oldfield EH, Doppman JL, Nieman LK et al (1991) Petrosal sinus sampling with and without corticotropin-releasing hormone for the differential diagnosis of Cushing’s syndrome. N Engl J Med 325:897–905PubMedCrossRef Oldfield EH, Doppman JL, Nieman LK et al (1991) Petrosal sinus sampling with and without corticotropin-releasing hormone for the differential diagnosis of Cushing’s syndrome. N Engl J Med 325:897–905PubMedCrossRef
65.
go back to reference Colao A, Faggiano A, Pivonello R, Pecori GF, Cavagnini F, Lombardi G (2001) Inferior petrosal sinus sampling in the differential diagnosis of Cushing’s syndrome: results of an Italian multicenter study. Eur J Endocrinol 144:499–507PubMedCrossRef Colao A, Faggiano A, Pivonello R, Pecori GF, Cavagnini F, Lombardi G (2001) Inferior petrosal sinus sampling in the differential diagnosis of Cushing’s syndrome: results of an Italian multicenter study. Eur J Endocrinol 144:499–507PubMedCrossRef
66.
go back to reference Swearingen B, Katznelson L, Miller K et al (2004) Diagnostic errors after inferior petrosal sinus sampling. J Clin Endocrinol Metab 89:3752–3763PubMedCrossRef Swearingen B, Katznelson L, Miller K et al (2004) Diagnostic errors after inferior petrosal sinus sampling. J Clin Endocrinol Metab 89:3752–3763PubMedCrossRef
67.
go back to reference Castinetti F, Morange I, Dufour H et al (2007) Desmopressin test during petrosal sinus sampling: a valuable tool to discriminate pituitary or ectopic ACTH-dependent Cushing’s syndrome. Eur J Endocrinol 157:271–277PubMedCrossRef Castinetti F, Morange I, Dufour H et al (2007) Desmopressin test during petrosal sinus sampling: a valuable tool to discriminate pituitary or ectopic ACTH-dependent Cushing’s syndrome. Eur J Endocrinol 157:271–277PubMedCrossRef
68.
go back to reference Miller DL, Doppman JL, Nieman LK et al (1990) Petrosal sinus sampling: discordant lateralization of ACTH-secreting pituitary microadenomas before and after stimulation with corticotropin-releasing hormone. Radiology 176:429–431PubMed Miller DL, Doppman JL, Nieman LK et al (1990) Petrosal sinus sampling: discordant lateralization of ACTH-secreting pituitary microadenomas before and after stimulation with corticotropin-releasing hormone. Radiology 176:429–431PubMed
69.
go back to reference Batista D, Gennari M, Riar J et al (2006) An assessment of petrosal sinus sampling for localization of pituitary microadenomas in children with Cushing disease. J Clin Endocrinol Metab 91:221–224PubMedCrossRef Batista D, Gennari M, Riar J et al (2006) An assessment of petrosal sinus sampling for localization of pituitary microadenomas in children with Cushing disease. J Clin Endocrinol Metab 91:221–224PubMedCrossRef
70.
go back to reference Lin LY, Teng MM, Huang CI et al (2007) Assessment of bilateral inferior petrosal sinus sampling (BIPSS) in the diagnosis of Cushing’s disease. J Chin Med Assoc 70:4–10PubMed Lin LY, Teng MM, Huang CI et al (2007) Assessment of bilateral inferior petrosal sinus sampling (BIPSS) in the diagnosis of Cushing’s disease. J Chin Med Assoc 70:4–10PubMed
71.
go back to reference Lienhardt A, Grossman AB, Dacie JE et al (2001) Relative contributions of inferior petrosal sinus sampling and pituitary imaging in the investigation of children and adolescents with ACTH-dependent Cushing’s syndrome. J Clin Endocrinol Metab 86:5711–5714PubMedCrossRef Lienhardt A, Grossman AB, Dacie JE et al (2001) Relative contributions of inferior petrosal sinus sampling and pituitary imaging in the investigation of children and adolescents with ACTH-dependent Cushing’s syndrome. J Clin Endocrinol Metab 86:5711–5714PubMedCrossRef
Metadata
Title
Dynamic testing in Cushing’s syndrome
Authors
Blerina Kola
Ashley B. Grossman
Publication date
01-06-2008
Publisher
Springer US
Published in
Pituitary / Issue 2/2008
Print ISSN: 1386-341X
Electronic ISSN: 1573-7403
DOI
https://doi.org/10.1007/s11102-007-0079-x

Other articles of this Issue 2/2008

Pituitary 2/2008 Go to the issue

OriginalPaper

Drugs and HPA axis

OriginalPaper

Drugs and prolactin

OriginalPaper

Male hypogonadism

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine